Tobramycin
Tobramycin Sulfate is an injectable antibiotic used to treat serious bacterial infections, such as those in the lungs, skin, or bloodstream. It belongs to the aminoglycoside class and is administered intravenously in a powdered form that must be mixed into a solution. This prescription drug is manufactured by Northstar Rx LLC under application ANDA211189. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tobramycin Sulfate is an injectable antibiotic used to treat serious bacterial infections, such as those in the lungs, skin, or bloodstream. It belongs to the aminoglycoside class and is administered intravenously in a powdered form that must be mixed into a solution. This prescription drug is manufactured by Northstar Rx LLC under application ANDA211189. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tobramycin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tobramycin — ANDA 209346 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209346"
}
]
|
| identifier | ANDA209346 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"fda",
"health-care",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tobramycin |
